newest glp-1 medications for type 2 diabetes 2025 In the phase 3 ACHIEVE-1 trial, published in June 2025, the oral small-molecule receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with glp-1 drugs for prediabetes New

Circular RNA COL1A2 mediates high glucose-induced oxidative stress and pyroptosis by regulating miR-424-5p/SGK1 in diabetic nephropathy

Mit einer ausgewogenen Ernhrung, regelmiger Bewegung, einer Optimierung der Darmgesundheit und gezielter Nahrungsergnzung kannst du die GLP-1-Produktion nachhaltig ankurbeln

small shot

By the end of the PIONEER 6 trial, 35% of patients diabetes and obesity who were treated with semaglutide had lost more than 5% of their body weight, and 15% had lost more than 10%

A Research Overview of the Mitochondrial-Derived Peptide Jul 08, 2026 MOTS-C is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded within the...

Experimental trials in animals further conclude that L-carnitine supplementation can reduce lipid deposition and increase the metabolites related to -oxidation, which confirm the importance of L-carnitine in controlling oxidative stress, steatosis, and fibrosis in the liver (87, 99)